Journal of Applied Biological Chemistry

The Korean Society for Applied Biological Chemistry (한국응용생명화학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of increasing nitric oxide and dihydrotestosterone by Taraxacum coreanum extract

포공영(Taraxacum coreanum) 추출물에 의한 산화 질소 및 dihydrotestosterone 증가 효과

  • Mo, SangJoon (Medical Laser Research Center, Dankook University)
  • Received : 2019.07.24
  • Accepted : 2019.09.06
  • Published : 2019.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Men's climactic syndrome, andropause, or testosterone deficit syndrome, is one of the new problems with the health of older men in the age of aging. This phenomenon is a natural phenomenon occurring in men as they age, clinically characterized by a decrease in blood testosterone levels and a marked decrease in physical and mental activity. The purpose of this study was to investigate the effect of hydrothermal extract of Taraxacum coreanum by comparing the levels of nitric oxide (NO) in the cavernosum and the levels of male hormone in the blood. Taraxacum coreanum extract increased NO production in vitro and in vivo in a dose-dependent manner. Levels of dihydrotestosterone and 17-hydroxyysteroid dehydrogenases, as well as levels of neurogenic nitric oxide synthase and cGMP, increased significantly in elderly rats (22 weeks) after 4 weeks of daily intake of Taraxacum coreanum extract. However, prostaglandin $E_2$, testosterone, and sexually-hormone-binding globulin levels were not different among all groups. Furthermore, total sperm and motile sperm counts were also no significant difference. Overall, these results suggest the possibility of Taraxacum coreanum extract as a safe and effective natural substance for enhancing NO, cGMP and free testosterone.

남성의 클라이맥스 증후군, 남성갱년기, 또는 테스토스테론 결핍 증후군은 고령화시대 남성노인들의 건강에 새로운 문제 중 하나이다. 이 현상은 나이가 들수록 남성에게서 나타나는 자연현상으로 혈중 테스토스테론 수치의 감소와 신체적 및 정신적 활동의 현저한 감소를 특징으로 한다. 이 연구의 목적은 해면체내 일산화질소(NO)와 혈액 내 남성호르몬의 수준을 비교하여 포공영(Taraxacum coreanum) 열수 추출물의 효과를 조사하였다. 포공영 추출물은 생체외 및 생체내에서 NO 생산량을 용량 의존적으로 증가시켰다. 포고영 추출물을 4 주간 섭취 한 나이든 쥐(22주)에서 다이하이드로 테스토스테론과 17-하이드록시 스테로이드 탈수소효소의 수준과 신경 인산화 질소 합성효소와 cGMP의 양은 유의하게 증가했다. 그러나 프로스타글란딘$E_2$, 테스토스테론 및 성 호르몬 결합 글로불린 수치는 모든 군에서 차이가 없었다. 또한, 총 정자 수 및 운동성 정자 수 또한 유의한 차이가 없었다. 전반적으로, 이러한 결과는 NO, cGMP 및 유리 테스토스테론을 향상시키기 위한 안전하고 효과적인 천연물질로서 Taraxacum coreanum 추출물의 가능성을 시사한다.

Keywords

References

  1. Hofer HG (2011) Men in a critical age: Kurt Mendel and the controversy over the male climacterium. Urologe A 50: 839-845 https://doi.org/10.1007/s00120-011-2559-x
  2. Burnett AL (2006) Nitric oxide in the penis-science and therapeutic implications from erectile dysfunction to priapism. J Sex Med 3: 578-582 https://doi.org/10.1111/j.1743-6109.2006.00270.x
  3. Jouannet P, Wang C, Eustach F, Kold-Jensen T, Auger J (2001) Semen quality and male reproductive health: the controversy about human sperm concentration decline. APMIS 109: 333-344 https://doi.org/10.1034/j.1600-0463.2001.090502.x
  4. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM (2010) Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocr Metab 95: 2536-2559 https://doi.org/10.1210/jc.2009-2354
  5. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FCW (2009) ISA, ISSAM, EAU, EAA and ASA recommendations: Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 12: 5-12 https://doi.org/10.1080/13685530802389628
  6. Bivalacqua TJ, Champion HC, Mehta YS, Abdel-Mageed AB, Sikka SC, Ignarro LJ, Kadowitz PJ, Hellstrom WJ (2000) Adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis improves age-related erectile dysfunction in the rat. Int J Impot Res 12:S8-S17 https://doi.org/10.1038/sj.ijir.3900556
  7. Jung WS (2008) Pharmacological management of male sexual dysfunction. J Korean Med Assoc 51:770-778 https://doi.org/10.5124/jkma.2008.51.8.770
  8. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ (1992) Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 326:90-94 https://doi.org/10.1056/NEJM199201093260203
  9. Vanhoutte PM, Boulanger CM, Mombouli JV (1995) Endotheliumderived relaxing factors and converting enzyme inhibition. Am J Cardiol 76: 3E-12E https://doi.org/10.1016/S0002-9149(99)80496-2
  10. Nimmegeers S, Sips P, Buys E, Decaluwe K, Brouckaert P, Van de Voorde J (2008) Role of the soluble guanylyl cyclase alpha1-subunit in mice corpus cavernosum smooth muscle relaxation. Int J Impot Res 20:278-284 https://doi.org/10.1038/sj.ijir.3901627
  11. Lowenstein CJ, Snyder SH (1992) Nitric oxide, a novel biologic messenger. Cell 70: 705-707 https://doi.org/10.1016/0092-8674(92)90301-R
  12. Bredt DS, Ferris CD, Snyder SH (1992) Nitric oxide synthase regulatory sites. phosphorylation by cyclic AMPdependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase; identification of flavin and calmodulin binding sites. J Biol Chem 267: 10976-10981 https://doi.org/10.1016/S0021-9258(19)49862-1
  13. Choi B, Kumar S, Zhao C, Zhang L, Kim C, Lee S, Jeon J, So I, Kim S, Park N (2015) Additive effects of Artemisia capillaris extract and scopoletin on the relaxation of penile corpus cavernosum smooth muscle. Int J Impot Res 27: 225-232 https://doi.org/10.1038/ijir.2015.23
  14. Cunningham GR (2013) Andropause or male menopause? Rationale for testosterone replacement therapy in older men with low testosterone levels. Endocr Pract 19: 847-852 https://doi.org/10.4158/EP13217.RA
  15. Staerman F, Lone P (2012) Andropause (androgen deficiency of the aging male): diagnosis and management. Minerva Med 103: 333-342
  16. Bae KH (2000) The medical plants of Korea. Kynhak Pub. Cp., Seoul Korea.
  17. Lee EB, Kim JK, Kim OK (1993) The antigastritic effect of Taraxaci Herba. Kor J Pharmacogn 24: 313-318
  18. Kang MJ, Kim KS (2001) Current trends of research and biological activities od dandelion. Food Ind Nutr 6: 60-67
  19. Shon YW (2017) Discrimination of Taraxaci Herba. Sung RS, Sim YH, Kim JH, Kang IH, Hyun SY, Lee GH, Lee JJ, Hwang DS, Kim GY, Kim SH (Ed.), Cheongju, National Institute of Food and Drug Safety Evaluation
  20. Williams CA, Goldstone F, Greenham J (1996) Flavonoids, cinnamic acids and coumarins from the different tissues and medicinal preparations of Taraxacum officinale. Phytochemistry 42: 121-127 https://doi.org/10.1016/0031-9422(95)00865-9
  21. Schutz K, Carle R, Schieber A (2006) Taraxacum-A review on its phytochemical and pharmacological profile. J Ethnopharmacol 107:313-323 https://doi.org/10.1016/j.jep.2006.07.021
  22. Budzianowski J (1997) Coumarins, caffeoyltartaric acids and their artifactual methyl esters from Taraxacum officinale leaves. Planta Med 63: 288-289 https://doi.org/10.1055/s-2006-957681
  23. Kim J-E, Yang S-J, Cho S-H, Park K-M (2015) Effects of Taraxaci Herba on the Sex Hormon Changes and Lipid Metabolism in the Ovariectomized Rats. J Korean Obstet Gynecol 28: 1-12
  24. Lee HS, Baek YS, Kim YS, Kim HP (2016) Effects of Fermented Dandelion (Taraxacum coreanum) Extract on Male Climacteric Syndrome. J Life Sci 26: 1063-1073 https://doi.org/10.5352/JLS.2016.26.9.1063
  25. Kim DH, Jung YH, Lee JW, Rho YH, Park JE, Lee SA (2014) Korea Patent No. 1014601260000. Daejeon: Korean Intellectual Property Office
  26. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM (2006) Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 91: 1995-2010 https://doi.org/10.1210/jc.2005-2847
  27. Roberfroid MB (2003) Introducing inulin-type fructans. Br J Nutr 93:13-26 https://doi.org/10.1079/BJN20041350
  28. Yao X, Li G, Bai Q, Xu H, LC (2013). Taraxerol inhibits LPS-induced inflammatory responses through suppression of TAK1 and Akt activation. Int Immunopharmacol 15: 316-324 https://doi.org/10.1016/j.intimp.2012.12.032
  29. Wilt T, Ishani A, MacDonald R, Stark G, Mulrow C, Lau J (2000) Betasitosterols for benign prostatic hyperplasia. The Cochrane Library (2):CD001043.
  30. Kim TH, Lim HJ, Kim MS, Lee MS (2012) Dietary supplements for benign prostatic hyperplasia: An overview of systematic reviews. Maturitas 73: 180-185 https://doi.org/10.1016/j.maturitas.2012.07.007
  31. Dashwood MR, Crump A, Shi-Wen X, Loesch A (2011) Identification of neuronal nitric oxide synthase (nNOS) in human penis: a potential role of reduced neuronally-derived nitric oxide in erectile dysfunction. Curr Pharm Biotechnol 12: 1316-1321 https://doi.org/10.2174/138920111798280965
  32. Fukuhara S, Tsujimura A, Okuda H, Yamamoto K, Takao T, Miyagawa Y, Nonomura N, Okuyama A (2011) Vardenafil and resveratrol synergistically enhance the nitric oxide/cyclic guanosine monophosphate pathway in corpus cavernosal smooth muscle cells and its therapeutic potential for erectile dysfunction in the streptozotocin-induced diabetic rat: preliminary findings. J Sex Med 8: 1061-1071 https://doi.org/10.1111/j.1743-6109.2010.02193.x
  33. Regis L, Planas J, Celma A, de Torres IM, Ferrer R, Morote J (2014) Behavior of total and free serum testosterone as a predictor for the risk of prostate cancer and its aggressiveness. Actas Urol Esp 39: 573-581
  34. Efesoy O, Cayan S, Akbay E (2018) The effect of testosterone replacement therapy on penile hemodynamics in hypogonadal men with erectile dysfunction, having veno-occlusive dysfunction. Am J Men's Health 12: 634-638 https://doi.org/10.1177/1557988318754931
  35. Ho CH, Wu CC, Chen KC, Jaw FS, Yu HJ, Liu SP (2016) Erectile dysfunction, loss of libido and low sexual frequency increase the risk of cardiovascular disease in men with low testosterone. Aging Male Off. J Int Soc Study Aging Male 19: 96-101 https://doi.org/10.3109/13685538.2015.1129400
  36. Celik O, Yucel S (2013) Testosterone replacement therapy: should it be performed in erectile dysfunction? Nephro Urol Mon 5: 858-861 https://doi.org/10.5812/numonthly.11523
  37. Kataoka T, Hotta Y, Ohno M, Maeda Y, Kimura K (2013) Limited effect of testosterone treatment for erectile dysfunction caused by highestrogen levels in rats. Int J Impot Res 25: 201-205 https://doi.org/10.1038/ijir.2013.21
  38. Aslan Y, Guzel O, Balci M, Tuncel A, Yildiz M, Atan A (2014) The impact of metabolic syndrome on serum total testosterone level in patients with erectile dysfunction. Aging Male Off. J Int Soc Study Aging Male 17: 76-80 https://doi.org/10.3109/13685538.2014.895318
  39. Greenspan MB, Barkin J (2012) Erectile dysfunction and testosterone deficiency syndrome: the "portal to men's health". Can J Urol 19: 18-27
  40. An TG, Jeong JC (2005) Effect of Ojawhan on the ethanol-induced erectiledysfunction in rats. Korean J Orient Int Med 26: 605-614
  41. Milman N, Burton CM, Iversen M, Videbaek R, Jensen CV, Carlsen J (2008) Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil? J Heart Lung Transpl 27: 329-334 https://doi.org/10.1016/j.healun.2007.11.576
  42. Kim SH, Kang KW, Kim KW, Kim ND (2000) Procyanidins in crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta. Life Sci 67: 121-131 https://doi.org/10.1016/S0024-3205(00)00608-1
  43. Xie YW, Ming DS, Xu HX, Dong H, But PPH (2000) Vasorelaxing effect of Caesalpinia sappan involvement of endogenous nitric oxide. Life Sci 67: 1913-1918 https://doi.org/10.1016/S0024-3205(00)00772-4

Cited by

  1. 화장품 소재로서의 꽃 10 종 에탄올추출물 생리활성 특성연구 vol.28, pp.4, 2019, https://doi.org/10.7783/kjmcs.2020.28.4.260